This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Environmental Technology Fund Partners and E-Leather
Gandhi, Vikram; Sesia, AldoCase HBS-318001-EFinanceIt is 2014 and Environmental Technologies Fund (ETF) Partners, a U.K.-based venture capital firm, has an opportunity to invest in a privately-held U.K. company that manufactured engineered composition leather extracted from waste leather using an environmentally-friendly process. The end product looked, smelled and felt like natural leather. Scalable marketplace adoption of E-Leather's products looked promising, but was just that-promising. And t...Starting at €8.20
-
Comergent Technologies Inc.: Enterprise E-Commerce, Teaching Note
Rangan, V. Kasturi; Bellfor, MarieTeaching Note HBS-507087-EMarketingTeaching Note to (505-016). An abstract is not available for this product.Starting at €0.00
-
The Chad-Cameroon Petroleum Development and Pipeline Project (E)
Esty, Benjamin C.; Sesia, AldoCase HBS-209082-EFinanceStarting at €5.74
-
COFCO Xinjiang Tunhe Co., Ltd. (Spanish Version)
Bell, David E.; Sesia, AldoCase HBS-515S08MarketingEn 2005, COFCO Ltd., una de las compañías más grandes y exitosas de China, Xinjiang adquirida Tunhe, un tomate de procesamiento firme, que había sido, en los últimos años, mal gestionado. COFCO cambió el equipo directivo de Tunhe y se dispuso a crear una cultura de profesionalismo e impresionó a los empleados que el cliente era lo primero. Qin Yelong, presidente Tunhe, tenía metas ambiciosas para la compañía. quería Tunhe a ser el mayor proveedor...Starting at €8.20
-
PureCircle
Bell, David E.; Sesia, AldoCase HBS-510032-EStrategyIn December 2008, the U.S. Food and Drug Administration (FDA determined that high-purity Rebaudioside A (Reb A), a natural and calorie-free product that a young company named PureCircie manufactured from the Stevia plant, could be used in beverages, foods, and as a table top sweetener in the U.S.-the largest market for sugar and sweeteners in the world. While the FDA's determination was the breakthrough the company had hoped for, much remained un...Starting at €8.20
-
COFCO Xinjiang Tunhe Co., Ltd.
Bell, David E.; Sesia, AldoCase HBS-508079-EMarketingIn 2005, COFCO Ltd., one of China's largest and most successful companies, acquired Xinjiang Tunhe, a tomato processing firm, which had been, in recent years, poorly managed. COFCO changed Tunhe's management team and set out to create a culture of professionalism and impressed upon the employees that the customer came first. Qin Yelong, Tunhe president, had ambitious goals for the company. he wanted Tunhe to be the world's largest supplier of tom...Starting at €8.20
-
Discovery Limited
Porter, Michael E.; Kramer, Mark R.; Sesia, AldoCase HBS-715423-EStrategyDiscovery Ltd. is a South-African based insurance company. Started in the early 1990s, Discovery used behavioral economics and data collection to innovate in the health care insurance industry. Its founder Adrian Gore believed that the company's products needed to not only make money but have a positive impact on society. Using its Vitality Wellness program as its strategic lynchpin, Discovery expanded into other insurance areas and financial ser...Starting at €8.20
-
Gilead: Hepatitis-C Access Strategy (A)
Rangan, V. Kasturi; Rangan, Vikram; Bloom, David E.Case HBS-515025-EGilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the disease. The company had earned accolades for its work in HIV/AIDS, where its innovative medicines now accounted for 60% of all patients on Anti-Retroviral (ARV) medicines. Much of thi...Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Rabobank: The Global Food and Agriculture Bank
Bell, David E.; Goldberg, Ray A.; Shelman, Mary; Sesia, AldoCase HBS-510024-ERabobank decides to focus primarily on food and agriculture firms and farms on a global basis.Starting at €8.20